110 related articles for article (PubMed ID: 19442654)
1. Proliferative and anti-proliferative effects of thymosin alpha1 on cells are associated with manipulation of cellular ROS levels.
Qin Y; Chen FD; Zhou L; Gong XG; Han QF
Chem Biol Interact; 2009 Aug; 180(3):383-8. PubMed ID: 19442654
[TBL] [Abstract][Full Text] [Related]
2. Anti-proliferative effects of the novel squamosamide derivative (FLZ) on HepG2 human hepatoma cells by regulating the cell cycle-related proteins are associated with decreased Ca(2+)/ROS levels.
Qin Y; Pan X; Tang TT; Zhou L; Gong XG
Chem Biol Interact; 2011 Sep; 193(3):246-53. PubMed ID: 21835169
[TBL] [Abstract][Full Text] [Related]
3. [The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].
Ma YL; Zheng Z; Li BD; Xie SJ; Li GX; Yan QH; Cai JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1046-9. PubMed ID: 17988589
[TBL] [Abstract][Full Text] [Related]
4. A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects.
Lao X; Li B; Liu M; Shen C; Yu T; Gao X; Zheng H
Apoptosis; 2015 Oct; 20(10):1307-20. PubMed ID: 26283169
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer.
Wang F; Li B; Fu P; Li Q; Zheng H; Lao X
Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059
[TBL] [Abstract][Full Text] [Related]
6. Thymosin alpha1 suppresses proliferation and induces apoptosis in human leukemia cell lines.
Fan YZ; Chang H; Yu Y; Liu J; Wang R
Peptides; 2006 Sep; 27(9):2165-73. PubMed ID: 16644063
[TBL] [Abstract][Full Text] [Related]
7. A tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1.
Lao X; Liu M; Chen J; Zheng H
PLoS One; 2013; 8(8):e72242. PubMed ID: 23977262
[TBL] [Abstract][Full Text] [Related]
8. Effect of a C-end rule modification on antitumor activity of thymosin α1.
Wang F; Xu C; Peng R; Li B; Shen X; Zheng H; Lao X
Biochimie; 2018 Nov; 154():99-106. PubMed ID: 30096371
[TBL] [Abstract][Full Text] [Related]
9. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1.
Yuan C; Zheng Y; Zhang B; Shao L; Liu Y; Tian T; Gu X; Li X; Fan K
Biochem Biophys Res Commun; 2015 Aug; 464(1):249-55. PubMed ID: 26111447
[TBL] [Abstract][Full Text] [Related]
10. Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.
Li W; Song L; Wu S; Xue X; Zhang L; He L; Han W; Wang Q; Ling R; Zhang W; Yan Z; Zhang Y
Int J Biol Sci; 2011; 7(5):618-28. PubMed ID: 21647330
[TBL] [Abstract][Full Text] [Related]
11. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F
Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552
[TBL] [Abstract][Full Text] [Related]
12. Clonal growth inhibition as a bioassay for thymosin alpha1: inactivation of Talpha1 by trifluroacetic acid.
Bianco-Batlles D; Naylor CW; Moshier JA; Dosescu J; Naylor PH
Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):157-60. PubMed ID: 11292250
[TBL] [Abstract][Full Text] [Related]
13. Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation.
Binsfeld M; Hannon M; Otjacques E; Humblet-Baron S; Baudoux E; Beguin Y; Baron F; Caers J
Cancer Immunol Immunother; 2015 Aug; 64(8):989-98. PubMed ID: 25971542
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferative effects of recombinant iron superoxide dismutase on HepG2 cells via a redox-dependent PI3k/Akt pathway.
Lu M; Bi CS; Gong XG; Chen HM; Sheng XH; Deng TL; Xu KD
Appl Microbiol Biotechnol; 2007 Aug; 76(1):193-201. PubMed ID: 17387468
[TBL] [Abstract][Full Text] [Related]
15. Immunopharmacology of thymosin alpha1 and cytokine synergy.
Naylor PH; Quadrini K; Garaci E; Rasi G; Hadden JW
Ann N Y Acad Sci; 2007 Sep; 1112():235-44. PubMed ID: 17567942
[TBL] [Abstract][Full Text] [Related]
16. Thymosin alpha1. SciClone Pharmaceuticals.
Billich A
Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
[TBL] [Abstract][Full Text] [Related]
17. Thymosin alpha-1-transformed Bifidobacterium promotes T cell proliferation and maturation in mice by oral administration.
Shao C; Tian G; Huang Y; Liang W; Zheng H; Wei J; Wei C; Yang C; Wang H; Zeng W
Int Immunopharmacol; 2013 Mar; 15(3):646-53. PubMed ID: 23352493
[TBL] [Abstract][Full Text] [Related]
18. Expression of thymosin alpha1-thymopentin fusion peptide in Pichia pastoris and its characterization.
Gao D; Zhang X; Zhang J; Cao J; Wang F
Arch Pharm Res; 2008 Nov; 31(11):1471-6. PubMed ID: 19023544
[TBL] [Abstract][Full Text] [Related]
19. Thymosin-alpha1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes.
Yao Q; Doan LX; Zhang R; Bharadwaj U; Li M; Chen C
Immunol Lett; 2007 Jun; 110(2):110-20. PubMed ID: 17532057
[TBL] [Abstract][Full Text] [Related]
20. The modulation of thymosin alpha 1 in the maturation, differentiation and function of murine bone marrow-derived dendritic cells in the absence or presence of tumor necrosis factor-alpha.
Huang Y; Chen Z; Zhou C; Yao H; Li M; Xu C
Int Immunopharmacol; 2004 Apr; 4(4):539-46. PubMed ID: 15099531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]